Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postmarket Surveillance, Durable Equipment Payments On OIG Study List

This article was originally published in The Gray Sheet

Executive Summary

A close look at FDA's medical device adverse event reporting system is one of the projects on the HHS Office of Inspector General's list for the coming year

You may also be interested in...



HHS OIG Work Plan: FDA Oversight And DME, Inpatient Payments Make List

The Department of Health and Human Services Office of Inspector General 1outlined Oct. 1 more than 300 new and ongoing investigations on its to-do list for fiscal year 2009, including digging into how Medicare pays for durable medical equipment and examinations of hospital inpatient payments and FDA device oversight

HHS OIG Work Plan: FDA Oversight And DME, Inpatient Payments Make List

The Department of Health and Human Services Office of Inspector General 1outlined Oct. 1 more than 300 new and ongoing investigations on its to-do list for fiscal year 2009, including digging into how Medicare pays for durable medical equipment and examinations of hospital inpatient payments and FDA device oversight

HHS Inspector General Postpones Study Of FDA Conflict-Of-Interest Oversight

The HHS Office of Inspector General announced it will postpone a study of FDA and instead focus its conflict-of-interest enforcement efforts on the National Institutes of Health this year

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel